AKT1 and Alzheimer disease: Treatment with compound 4c significantly improved the pathological features of AD in 3 x Tg mice and APP/PS1 mice and activated the PI3K/AKT/GSK3β pathway, a central signaling pathway related to AD pathogenesis.